Portage Biotech Valuation
| PRTG Stock | USD 4.02 0.08 1.95% |
At this time, the company appears to be undervalued. Portage Biotech holds a recent Real Value of $5.47 per share. The prevailing price of the company is $4.02. Our model determines the value of Portage Biotech from analyzing the company fundamentals such as Shares Owned By Institutions of 17.80 %, shares outstanding of 1.12 M, and Return On Equity of -1.91 as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Portage Biotech's valuation include:
Undervalued
Today
Please note that Portage Biotech's price fluctuation is extremely dangerous at this time. Calculation of the real value of Portage Biotech is based on 3 months time horizon. Increasing Portage Biotech's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Portage stock is determined by what a typical buyer is willing to pay for full or partial control of Portage Biotech. Since Portage Biotech is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Portage Stock. However, Portage Biotech's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 4.02 | Real 5.47 | Target 10.0 | Hype 5.81 | Naive 3.9 |
The real value of Portage Stock, also known as its intrinsic value, is the underlying worth of Portage Biotech Company, which is reflected in its stock price. It is based on Portage Biotech's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Portage Biotech's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Portage Biotech helps investors to forecast how Portage stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Portage Biotech more accurately as focusing exclusively on Portage Biotech's fundamentals will not take into account other important factors: When choosing an evaluation method for Portage Biotech, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using all methods to arrive at a better estimate.
Portage Biotech Cash |
|
Portage Valuation Drivers Correlation
Many accounts on the financial statements of Portage Biotech are highly interrelated and sometimes correlated. Consequently, when conducting Portage's valuation analysis, one should examine all of the accounts reported to obtain a complete picture of its financial situation. We provide a unique feature to present a conventional correlation table purposely composed against different valuation-related drivers of Portage
Click cells to compare fundamentals
Portage Valuation Trend
Comparing Portage Biotech's enterprise value against its market capitalization is a good way to estimate the value of Portage Biotech uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
Portage Biotech Total Value Analysis
Portage Biotech is at this time anticipated to have valuation of 2.86 M with market capitalization of 4.61 M, debt of 47 K, and cash on hands of 21.18 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Portage Biotech fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
2.86 M | 4.61 M | 47 K | 21.18 M |
Portage Biotech Asset Utilization
One of the ways to look at asset utilization of Portage is to check how much profit was generated for every dollar of assets it reports. Portage Biotech holds a negative application of assets of -0.19 pct., losing $0.001942 for each dollar of assets held by the company. Inadequate asset utilization implies the company is being less effective with each dollar of assets it holds. Put it differently, asset utilization of Portage Biotech shows how discouraging it operates for each dollar spent on its assets.Portage Biotech Ownership Allocation
Portage Biotech has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares.Portage Biotech Profitability Analysis
Net Loss for the year was (75.34 M) with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Portage Biotech's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Portage Biotech and how it compares across the competition.
About Portage Biotech Valuation
The stock valuation mechanism determines Portage Biotech's current worth on a weekly basis. Our valuation model uses a comparative analysis of Portage Biotech. We calculate exposure to Portage Biotech's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Portage Biotech's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -62.1 K | -59 K | |
| Pretax Profit Margin | (13.23) | (13.89) | |
| Operating Profit Margin | (13.21) | (13.87) | |
| Net Loss | (13.23) | (13.89) | |
| Gross Profit Margin | (40.09) | (42.09) |
Portage Biotech Growth Indicators
Investing in growth stocks can be very risky. If the company such as Portage Biotech does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 20.3 M |
Portage Biotech Current Valuation Indicators
Valuation refers to the process of determining the present value of Portage Biotech and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Portage we look at many different elements of the entity such as Portage's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Portage Biotech, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Portage Biotech's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Portage Biotech's worth.Complementary Tools for Portage Stock analysis
When running Portage Biotech's price analysis, check to measure Portage Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Portage Biotech is operating at the current time. Most of Portage Biotech's value examination focuses on studying past and present price action to predict the probability of Portage Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Portage Biotech's price. Additionally, you may evaluate how the addition of Portage Biotech to your portfolios can decrease your overall portfolio volatility.
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |